Nuvation Bio NUVB
NYSE NUVB
$4.57 -0.12 (-2.56%)
At close: Oct 23, 2026 · 4:00 PM EDT

Nuvation Bio (NUVB) Amortization of Deferred Charges (2025 - 2026)

Updated

Analysis

Nuvation Bio (NUVB) Amortization of Deferred Charges (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Nuvation Bio 1.58 Bn -689.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 350,000.00
Mar 31, 2026 321,000.00
Dec 31, 2025 327,000.00
Sep 30, 2025 213,000.00
Jun 30, 2025 18,000.00
API Access

Nuvation Bio Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=NUVB&period=max&api_key=YOUR_API_KEY